Ozmosi | Nifuratel Drug Profile
Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

Nifuratel

Pronounced as: nye-FYUR-uh-tel

Alternative Names: nifuratel
Clinical Status: Active
Latest Update: 2024-03-27
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action:

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Bulgaria | Chile | China | Colombia | Croatia | Czech | Hong Kong | Hungary | India | Italy | Lithuania | Mexico | Pakistan | Peru | Poland | Russia | Slovakia | Taiwan | Turkey | Ukraine | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Jiangsu Wangao Pharmaceutical Co., Ltd.
Company Location:
Company Founding Year: None
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Nifuratel

Countries in Clinic: China

Active Clinical Trial Count: 1

Recent & Upcoming Milestones

Highest Development Phases

Phase 3: Candidiasis|Trichomonas Infections

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

CTR20232737

 CTR20232737

P3

Completed

Trichomonas Infections|Candidiasis

2025-04-30

2025-12-14

Patient Enrollment|Primary Completion Date|Study Completion Date|Treatments|Trial Status

Recent News Events

Date

Type

Title

03/27/2024

PubMed

 Selective Anticervical Cancer Injectable and Self-Healable Hydrogel Platforms Constructed of Drug-Loaded Cross-Linkable Unimolecular Micelles in a Single and Combination Therapy.

09/21/2023

PubMed

 Nifuratel reduces Salmonella survival in macrophages by extracellular and intracellular antibacterial activity.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions